What is the standard range for normal blood sugar levels

In our daily life, blood sugar level is an important physiological indicator that is related to our health status. Especially for patients with diabetes, it is very important to know the standard range of normal blood glucose. So, what is the standard range for normal blood sugar levels? For the question of "what is the standard range of normal blood glucose levels", the standard range of normal blood glucose levels actually varies from person to person, but generally speaking, the normal range of fasting whole blood glucose is 3.9-6.1 mmol/L, and the normal range of plasma glucose is 3.9-6.9 mmol/L. The normal range of blood glucose 1 hour after a meal is 6.7-9.4 mmol/L, and the normal range of blood glucose 2 hours after a meal is ≤ 7.8 mmol/L. For pregnant women, the normal range of fasting blood glucose is 3.3-5.1 mmol/L, the normal range of postprandial 1-hour blood glucose is ≤ 10.0 mmol/L, and the normal range of postprandial 2-hour blood glucose is ≤ 8.5 mmol/L. Overall, there may be certain differences among people of different ages and genders, so it is important for individuals to understand whether their blood sugar levels are within the normal range. Regular monitoring of blood glucose level is one of the key measures to prevent and control diabetes. In addition to focusing on the standard range of normal blood glucose levels, the treatment of hyperglycemia is also very important. Common methods for lowering blood sugar include dietary adjustments, exercise, and medication treatment. Among them, drug therapy is one of the important means to control high blood sugar. In recent years, new hypoglycemic drugs represented by Pingrunning Ligliptin have been increasingly recognized and favored by patients for their high efficacy, high safety, and convenient medication in the treatment of hyperglycemia. Dipeptidyl peptidase-4 (DPP-4) inhibitors, represented by Pingrunning Ligliptin, have significant advantages in the treatment of hyperglycemia. DPP-4 inhibitors are a novel hypoglycemic drug that reduces blood glucose levels by inhibiting the activity of DPP-4 enzyme and prolonging the action time of endogenous glucagon like peptide-1 (GLP-1). Compared with other traditional hypoglycemic drugs, DPP-4 inhibitors have the following advantages:

Significant hypoglycemic effect: DPP-4 inhibitors can effectively lower blood sugar levels and control postprandial and fasting blood sugar.

High safety: DPP-4 inhibitors have fewer adverse reactions, good tolerance, and long-term cardiovascular safety.

It has a protective effect on islet beta cells: DPP-4 inhibitor can protect islet beta cells and reduce the damage of diabetes to islet beta cells.

Improving insulin resistance: DPP-4 inhibitors can improve insulin resistance, increase insulin sensitivity, and help control the progression of the disease.

Reduce the risk of complications: DPP-4 inhibitor can reduce the risk of complications of diabetes, such as cardiovascular disease, retinopathy, etc., because it can control the blood sugar level steadily.

The above is an introduction to the question of "What is the standard range of normal blood glucose levels?" Understanding the standard range of normal blood glucose levels is an important part of maintaining health. Through reasonable diet adjustment, proper exercise and drug treatment, we can effectively control hyperglycemia and prevent diabetes and its complications. In particular, dipeptidyl peptidase-4 inhibitor represented by Pingrunning Liggliptin has significant advantages in the treatment of hyperglycemia, and is an ideal choice for diabetes patients!